Search research articles
Contact Us
Filters
Showing results (951-960 of 1,351) with videos related to
Page
of 136
Sort By:
Developmental Cell
|
December 17, 2021
WASp triggers mechanosensitive actin patches to facilitate immune cell migration in dense tissues
Florian Gaertner, Patricia Reis-Rodrigues, Ingrid de Vries, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells
Sergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Proteomics
|
April 27, 2017
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin
Sergey A Dyshlovoy, Katharina Otte, Simone Venz, et al.
International Journal of Cardiology
|
October 15, 2016
Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - A feasibility and safety study
Philine J Köln, Bruno Scheller, Houng Bang Liew, et al.
Revue Medicale Suisse
|
February 7, 2012
[Pediatrics]
C J Fischer, E Giannoni, A C Truttmann, et al.
The British Journal of Dermatology
|
February 19, 2009
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies
A Hauschild, E Stockfleth, G Popp, et al.
Breast Cancer Research and Treatment
|
August 11, 2010
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Jens Huober, Gunter von Minckwitz, Carsten Denkert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
Jean Jacques Grob, Thomas Jouary, Brigitte Dréno, et al.
Environment International
|
February 14, 2015
Exploring the planetary boundary for chemical pollution
Miriam L Diamond, Cynthia A de Wit, Sverker Molander, et al.
Page
of 136
Search research articles
Search
Showing results (951-960 of 1,351) with videos related to
Sort By:
Page
of 136
Developmental Cell
|
December 17, 2021
WASp triggers mechanosensitive actin patches to facilitate immune cell migration in dense tissues
Florian Gaertner, Patricia Reis-Rodrigues, Ingrid de Vries, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells
Sergey A Dyshlovoy, Dmitry N Pelageev, Lea S Jakob, et al.
Proteomics
|
April 27, 2017
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin
Sergey A Dyshlovoy, Katharina Otte, Simone Venz, et al.
International Journal of Cardiology
|
October 15, 2016
Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - A feasibility and safety study
Philine J Köln, Bruno Scheller, Houng Bang Liew, et al.
Revue Medicale Suisse
|
February 7, 2012
[Pediatrics]
C J Fischer, E Giannoni, A C Truttmann, et al.
The British Journal of Dermatology
|
February 19, 2009
Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies
A Hauschild, E Stockfleth, G Popp, et al.
Breast Cancer Research and Treatment
|
August 11, 2010
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Jens Huober, Gunter von Minckwitz, Carsten Denkert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2012
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
Jean Jacques Grob, Thomas Jouary, Brigitte Dréno, et al.
Environment International
|
February 14, 2015
Exploring the planetary boundary for chemical pollution
Miriam L Diamond, Cynthia A de Wit, Sverker Molander, et al.
Page
of 136